Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Sarepta Restructures, Cuts 500 Jobs As Elevidys-Related Deaths Impact Sales
R&D Reprioritization Eliminates Most Gene Therapy Programs
Jul 17 2025
•
By
Mandy Jackson
Sarepta laid off 500 people but promoted others in the C-suite, giving the execs raises
(Shutterstock)
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Strategy
More from Business